PL2806893T3 - System dostarczania leków - Google Patents

System dostarczania leków

Info

Publication number
PL2806893T3
PL2806893T3 PL13702817T PL13702817T PL2806893T3 PL 2806893 T3 PL2806893 T3 PL 2806893T3 PL 13702817 T PL13702817 T PL 13702817T PL 13702817 T PL13702817 T PL 13702817T PL 2806893 T3 PL2806893 T3 PL 2806893T3
Authority
PL
Poland
Prior art keywords
delivery system
drug delivery
drug
delivery
Prior art date
Application number
PL13702817T
Other languages
English (en)
Inventor
Heikki Lyytikäinen
Harri Jukarainen
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47666152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2806893(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of PL2806893T3 publication Critical patent/PL2806893T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PL13702817T 2012-01-23 2013-01-22 System dostarczania leków PL2806893T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20125069 2012-01-23
PCT/FI2013/050068 WO2013110856A1 (en) 2012-01-23 2013-01-22 A drug delivery system
EP13702817.1A EP2806893B1 (en) 2012-01-23 2013-01-22 A drug delivery system

Publications (1)

Publication Number Publication Date
PL2806893T3 true PL2806893T3 (pl) 2019-01-31

Family

ID=47666152

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13702817T PL2806893T3 (pl) 2012-01-23 2013-01-22 System dostarczania leków

Country Status (38)

Country Link
US (1) US10500381B2 (pl)
EP (1) EP2806893B1 (pl)
JP (1) JP6236401B2 (pl)
KR (1) KR102004014B1 (pl)
CN (1) CN104144702B (pl)
AR (1) AR089765A1 (pl)
AU (1) AU2013213514B2 (pl)
BR (1) BR112014017834B1 (pl)
CA (1) CA2861947A1 (pl)
CL (1) CL2014001935A1 (pl)
CO (1) CO7020911A2 (pl)
CR (1) CR20140358A (pl)
CU (1) CU24431B1 (pl)
CY (1) CY1120773T1 (pl)
DK (1) DK2806893T3 (pl)
DO (1) DOP2014000171A (pl)
EA (1) EA032208B1 (pl)
EC (1) ECSP14010605A (pl)
ES (1) ES2691635T3 (pl)
HR (1) HRP20181707T1 (pl)
IL (1) IL233599B (pl)
LT (1) LT2806893T (pl)
MX (1) MX355961B (pl)
MY (1) MY172812A (pl)
NZ (1) NZ627461A (pl)
PE (1) PE20141818A1 (pl)
PH (1) PH12014501654A1 (pl)
PL (1) PL2806893T3 (pl)
PT (1) PT2806893T (pl)
RS (1) RS57911B1 (pl)
SG (1) SG11201404032SA (pl)
SI (1) SI2806893T1 (pl)
TR (1) TR201815247T4 (pl)
TW (1) TWI626951B (pl)
UA (1) UA116197C2 (pl)
UY (1) UY34583A (pl)
WO (1) WO2013110856A1 (pl)
ZA (1) ZA201406206B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
PL2982352T3 (pl) * 2014-06-28 2019-01-31 Laboratorios Andrómaco S.A. Krążek szyjki macicy zawierający progesteron do długotrwałego, przedłużonego i ciągłego uwalniania, stosowany w celu zapobiegania przed przedwczesnym porodem
MX2018007674A (es) * 2015-12-21 2018-09-12 Bayer Oy Un metodo para la fabricacion de un anillo vaginal.
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
EP3687495A1 (en) * 2017-09-27 2020-08-05 Bayer Oy A method for modifying release of a therapeutically active agent from an elastomeric matrix
CN109954198B (zh) * 2017-12-25 2021-10-12 先健科技(深圳)有限公司 药物球囊及其制备方法
KR20210129090A (ko) * 2019-02-19 2021-10-27 파티클 사이언시스 인코포레이티드 구획화된 약물 전달 기기

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
AU2001258442A1 (en) 2000-05-10 2001-11-20 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
WO2002032433A1 (en) 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
PL367961A1 (pl) * 2001-08-31 2005-03-07 Schering Oy Układ podawania leku
DE10209979A1 (de) 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
EP2106790B1 (en) 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
ATE372772T1 (de) 2004-07-13 2007-09-15 Schering Oy Retardiertes freigabesystem mit kontrollierter initialabgabe
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
WO2006085335A2 (en) 2005-01-03 2006-08-17 Lupin Limited Pharmaceutical composition of acid labile substances
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
US8137327B2 (en) 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
ES2425842T3 (es) * 2006-11-20 2013-10-17 Intervet International B.V. Sistema de administración de fármaco con forma helicoidal
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI121000B (fi) 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
CN103347496A (zh) * 2010-12-27 2013-10-09 道康宁公司 药物递送分散体以及由其形成的膜

Also Published As

Publication number Publication date
NZ627461A (en) 2016-07-29
EP2806893A1 (en) 2014-12-03
UA116197C2 (uk) 2018-02-26
CU20140094A7 (es) 2014-11-27
TR201815247T4 (tr) 2018-11-21
PH12014501654B1 (en) 2014-10-13
LT2806893T (lt) 2018-12-10
HRP20181707T1 (hr) 2019-02-22
US10500381B2 (en) 2019-12-10
CN104144702B (zh) 2018-03-06
EP2806893B1 (en) 2018-07-18
PT2806893T (pt) 2018-11-09
CO7020911A2 (es) 2014-08-11
US20140350488A1 (en) 2014-11-27
CA2861947A1 (en) 2013-08-01
CY1120773T1 (el) 2019-12-11
CR20140358A (es) 2014-11-17
UY34583A (es) 2013-09-02
EA032208B1 (ru) 2019-04-30
AR089765A1 (es) 2014-09-17
MY172812A (en) 2019-12-12
BR112014017834A2 (pl) 2017-06-20
DK2806893T3 (en) 2018-11-05
BR112014017834B1 (pt) 2021-05-18
CU24431B1 (es) 2019-07-04
AU2013213514B2 (en) 2017-07-13
CN104144702A (zh) 2014-11-12
SG11201404032SA (en) 2014-08-28
KR20140127262A (ko) 2014-11-03
TWI626951B (zh) 2018-06-21
DOP2014000171A (es) 2014-08-15
PH12014501654A1 (en) 2014-10-13
EA201400834A1 (ru) 2014-12-30
ES2691635T3 (es) 2018-11-28
IL233599A0 (en) 2014-08-31
TW201343204A (zh) 2013-11-01
IL233599B (en) 2019-07-31
PE20141818A1 (es) 2014-12-18
MX355961B (es) 2018-05-07
JP2015504083A (ja) 2015-02-05
SI2806893T1 (sl) 2019-02-28
MX2014008906A (es) 2014-08-26
RS57911B1 (sr) 2019-01-31
KR102004014B1 (ko) 2019-07-25
BR112014017834A8 (pt) 2017-07-11
AU2013213514A1 (en) 2014-08-07
CL2014001935A1 (es) 2015-04-10
JP6236401B2 (ja) 2017-11-22
ZA201406206B (en) 2019-06-26
HK1203802A1 (en) 2015-11-06
ECSP14010605A (es) 2015-12-31
WO2013110856A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
ZA201500299B (en) Drug delivery device
IL236745A0 (en) Drug release device
SI3081249T1 (sl) Naprava za dajanje zdravila
ZA201502352B (en) Liposomal drug delivery system
EP2838511A4 (en) OCULAR MEDICATION DELIVERY SYSTEM
PL2665431T3 (pl) Technika dostarczania leków
ZA201309156B (en) Drug delivery system
EP2921152A4 (en) DRUG DELIVERY SYSTEM
SG11201404123XA (en) Medicament delivery devices
EP2842539A4 (en) DRUG DELIVERY SYSTEM
PL2793857T3 (pl) Technologia dostarczania leków
SG10202102293QA (en) A novel drug delivery system based on jcv-vlp
ZA201406206B (en) A drug delivery system
IL234912A0 (en) Drug release device
SG10201609440WA (en) Multi-additive delivery system
IL236354A0 (en) Arrangement for drug delivery device
GB2504558B8 (en) A delivery aid
HUE049542T2 (hu) Gyógyszerbejuttató eszköz
HUE049546T2 (hu) Gyógyszerbejuttató eszköz
GB201218668D0 (en) Drug delivery device